MEDICLINIC INTERNATIONAL PLC - Appointment of Danie Meintjes as designated Non-executive Director for engagement with the Company's workforce

Appointment of Danie Meintjes as designated Non-executive Director for engagement with the Company's workforce

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")

29 March 2019

Appointment of Danie Meintjes as designated Non-executive Director for engagement with the
Company's workforce

The Company is pleased to announce the appointment of Danie Meintjes as designated Non-
executive Director for engagement with the Company's workforce, in line with the provisions of the UK
Corporate Governance Code (July 2018), with effect from 1 April 2019. Danie retired as Chief
Executive Officer ("CEO") on 1 June 2018 and continues to serve as a Non-executive Director.

Dr Edwin Hertzog, Group Chairman, said:

"I am pleased to announce that Danie Meintjes has been appointed as the designated Non-executive
Director for engagement with the Company's workforce. As the former Group CEO and with his prior
experience as Divisional HR Executive, Danie was closely involved with the Company's approach to
engaging with, investing in and rewarding our people. With his wealth of knowledge and experience
gained in different capacities over 30 years at Mediclinic, Danie is extremely well-positioned to
engage effectively with our people. The Board of Directors welcomes Danie’s appointment to this role
and thanks him for taking on this additional responsibility".

Danie Meintjes said:

"I am delighted to be taking on this important role with specific responsibility for Mediclinic’s
workforce. Taking proper account of our peoples’ interests, alongside those of other stakeholders, is
an important part of our Board culture, and this will be strengthened further by creating a specific
responsibility for workforce engagement on the Board, which I feel well-equipped to fulfil, given my
many years of involvement with the Company".

About Mediclinic International plc
Mediclinic is an international private healthcare services group with operating divisions in Switzerland,
Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary
healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-
listed and UK-based private healthcare group.

Mediclinic comprises 76 hospitals and 28 clinics. Hirslanden operates 18 private hospitals and 4
clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operates 48
hospitals and 4 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100
inpatient beds in total; and Mediclinic Middle East operates 7 hospitals and 20 clinics with more than
900 inpatient beds in the United Arab Emirates.

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary
listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

Date: 29/03/2019 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.